ATE382684T1 - Avipox-vektor, der für ein hiv-antigen und gamma- interferon kodiert. - Google Patents
Avipox-vektor, der für ein hiv-antigen und gamma- interferon kodiert.Info
- Publication number
- ATE382684T1 ATE382684T1 AT99957232T AT99957232T ATE382684T1 AT E382684 T1 ATE382684 T1 AT E382684T1 AT 99957232 T AT99957232 T AT 99957232T AT 99957232 T AT99957232 T AT 99957232T AT E382684 T1 ATE382684 T1 AT E382684T1
- Authority
- AT
- Austria
- Prior art keywords
- hiv antigen
- gamma interferon
- vector coding
- avipox vector
- avipox
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/57—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPP7007A AUPP700798A0 (en) | 1998-11-09 | 1998-11-09 | Recombinant viral constructs and methods relating thereto |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE382684T1 true ATE382684T1 (de) | 2008-01-15 |
Family
ID=3811220
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99957232T ATE382684T1 (de) | 1998-11-09 | 1999-11-09 | Avipox-vektor, der für ein hiv-antigen und gamma- interferon kodiert. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7276242B1 (de) |
| EP (1) | EP1129177B1 (de) |
| JP (2) | JP4596647B2 (de) |
| AT (1) | ATE382684T1 (de) |
| AU (1) | AUPP700798A0 (de) |
| CA (1) | CA2350127C (de) |
| DE (1) | DE69937900T2 (de) |
| HK (1) | HK1040417B (de) |
| NZ (1) | NZ511567A (de) |
| WO (1) | WO2000028003A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6544780B1 (en) * | 2000-06-02 | 2003-04-08 | Genphar, Inc. | Adenovirus vector with multiple expression cassettes |
| CA2419822C (en) * | 2000-08-14 | 2011-02-08 | Gary J. Nabel | Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| WO2002102404A1 (en) * | 2001-06-18 | 2002-12-27 | Institut National De La Recherche Agronomique | Uses of cytokines |
| AU2004281298B2 (en) * | 2003-10-15 | 2010-05-13 | Virax Development Pty Ltd | Poxvirus vector encoding retrovirus (eg HIV) and cytokine |
| CA2542155A1 (en) * | 2003-10-15 | 2005-04-28 | Virax Development Pty Ltd | Poxvirus vector encoding retrovirus (eg hiv) and cytokine |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5833975A (en) * | 1989-03-08 | 1998-11-10 | Virogenetics Corporation | Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence |
| US5866136A (en) * | 1986-08-01 | 1999-02-02 | Commonwealth Scientific And Industrial Organisation | Recombinant vaccine |
| AU612983B2 (en) * | 1986-08-01 | 1991-07-25 | Australian National University, The | Recombinant vaccine |
| US5766598A (en) * | 1991-03-07 | 1998-06-16 | Virogenetics Corporation | Recombinant attenuated ALVAC canarypoxvirus expression vectors containing heterologous DNA segments encoding lentiviral gene products |
| EP1156102A1 (de) * | 1991-06-14 | 2001-11-21 | Virogenetics Corporation | Rekombinanter hiv-spezifischer Impfstoff aus Poxvirus |
-
1998
- 1998-11-09 AU AUPP7007A patent/AUPP700798A0/en not_active Abandoned
-
1999
- 1999-11-09 CA CA2350127A patent/CA2350127C/en not_active Expired - Fee Related
- 1999-11-09 NZ NZ511567A patent/NZ511567A/en not_active IP Right Cessation
- 1999-11-09 AT AT99957232T patent/ATE382684T1/de active
- 1999-11-09 JP JP2000581170A patent/JP4596647B2/ja not_active Expired - Fee Related
- 1999-11-09 US US09/831,307 patent/US7276242B1/en not_active Expired - Fee Related
- 1999-11-09 DE DE69937900T patent/DE69937900T2/de not_active Expired - Lifetime
- 1999-11-09 EP EP99957232A patent/EP1129177B1/de not_active Expired - Lifetime
- 1999-11-09 WO PCT/AU1999/000989 patent/WO2000028003A1/en active IP Right Grant
-
2002
- 2002-03-04 HK HK02101632.0A patent/HK1040417B/zh not_active IP Right Cessation
-
2010
- 2010-06-23 JP JP2010142877A patent/JP2010279361A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AUPP700798A0 (en) | 1998-12-03 |
| JP2010279361A (ja) | 2010-12-16 |
| DE69937900T2 (de) | 2009-01-02 |
| JP4596647B2 (ja) | 2010-12-08 |
| NZ511567A (en) | 2003-09-26 |
| JP2002529076A (ja) | 2002-09-10 |
| EP1129177A4 (de) | 2005-04-13 |
| DE69937900D1 (de) | 2008-02-14 |
| US7276242B1 (en) | 2007-10-02 |
| HK1040417A1 (en) | 2002-06-07 |
| WO2000028003A1 (en) | 2000-05-18 |
| CA2350127C (en) | 2011-01-04 |
| HK1040417B (zh) | 2008-07-18 |
| CA2350127A1 (en) | 2000-05-18 |
| EP1129177A1 (de) | 2001-09-05 |
| EP1129177B1 (de) | 2008-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2194029T3 (es) | Variantes del virus hiv-2. | |
| CY1108299T1 (el) | Πεπτιδια του ιου ανθρωπινης ανοσοανεπαρκειας (hiv), αντιγονα και συνθεσεις εμβολιου | |
| BR9916896A (pt) | Diaril aminas substituìdas com 1-heterociclo | |
| NO20011861L (no) | Interferon-<beta> fusjonsproteiner samt anvendelse derav | |
| TR200202194T2 (tr) | Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri | |
| ATE330575T1 (de) | Dentalmaterialien mit verlängerter verarbeitungszeit, kits und verfahren | |
| NO20052363L (no) | Interferon-alfa polypeptider og konjugater | |
| DK1353689T3 (da) | Immuniseringspræparater og anvendelse deraf | |
| CY1117746T1 (el) | Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna | |
| CY1109221T1 (el) | Χιμαιρικο γονιδιο που κωδικοποιει τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum | |
| ATE175119T1 (de) | Vakzine gegen immunodefizienz-virus der katze (kiv) | |
| ATE382684T1 (de) | Avipox-vektor, der für ein hiv-antigen und gamma- interferon kodiert. | |
| NO910982D0 (no) | Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller. | |
| ATE390482T1 (de) | Interleukin-1 hy2. mittel und verfahren | |
| DE60026150D1 (de) | Diagnostika und therapeutika für osteoporose | |
| DE69625356D1 (de) | cDNA KLON FÜR DEN SÜDAFRIKANISCHEN ARBOVIRUS NO.86 | |
| AU5322800A (en) | Cloned genone of infectious hepatitis c virus of genotype 2a and uses thereof | |
| DK0643719T3 (da) | Nukleinsyresekvenser, som koder for eller er komplementære til nukleinsyresekvenser, som koder for interleukin 9-receptor | |
| ATE429496T1 (de) | Gpr54 'knock-out' säugetiere und screening- verfahren, die sie verwenden | |
| IT1249684B (it) | Epitopi della proteina env del virus dell'epatite c. | |
| NO902087L (no) | Alfa-amylase-pullulanase-enzym og dna-sekvens som koder for dette, rekombinant dna-molekyl og en rekombinant klon som uttrykker enzymet. | |
| ES2074422T3 (es) | Moleculas de adn y arn del subtipo accidental del virus fsma, polipeptidos, que son codificados por estas moleculas, y su uso. | |
| ES2171549T3 (es) | Or-1 en receptor huerfano perteneciente a la familia de receptores nucleares. | |
| DE50304603D1 (de) | Impfstoff gegen infektionen mit onkoviren, wie dem felinen leukosevirus der katze | |
| DE60040668D1 (de) | Antibakterielles protein chlamysin-b, dafür kodierendes gen und ein expresionssystem dafür |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1129177 Country of ref document: EP |